According to a U.S. media report on April 23, local time, following the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommending a suspension of vaccination against Johnson & Johnson's new crown vaccine in the U.S. due to the potential risk of thrombosis, The Centers for Disease Control and Prevention of the United States received two reports of similar thrombosis cases. One of them was a woman in her 50s from Oregon. The woman was vaccinated with Johnson & Johnson before the suspension of vaccination was announced by Oregon. She died of a severe blood clot within two weeks of the vaccination. Another adult woman from Texas also developed similar symptoms after vaccination and is currently receiving treatment in the hospital.
It is reported that six cases of thrombosis have been reported among the 7 million Johnson & Johnson vaccinators nationwide in the United States, including one death. The US Centers for Disease Control and Prevention's Immunization Advisory Committee has held an emergency meeting on this issue on the 14th local time, but has not made a final decision. It is expected that the group will meet again on the 23rd local time to discuss the relationship between thrombosis and vaccination based on the findings of the investigation. contact.
